Will JP Morgan’s AI Advisor Be a Winner?
JPMorgan Chase is rolling out “JPM WealthAI for high-net-worth clients.…
Sell
20
SWTX Quote, Financials, Valuation and Earnings
Last price:
$36.47
Seasonality move
:
5.59%
Day range:
$33.57 - $36.53
52-week range:
$28.21 - $62.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
14.11x
P/B ratio:
5.68x
Volume:
2M
Avg. volume:
2.3M
1-year change:
-17.32%
Market cap:
$2.7B
Revenue:
$191.6M
EPS (TTM):
-$3.48
SWTX Analysts' Consensus Rating
The 5 analysts providing 12-month price projections for SpringWorks Therapeutics shares anticipate an average target of $72.88, ranging from a low estimate of $63.00 to a high estimate of $87.00. This average target implies a growth of 99.82% compared to the current stock price of $36.47.
Consensus Price Target
$72.88
Highest Price Target
$87.00
Lowest Price Target
$63.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 4 | 0 | 5 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | -- | Buy |
SWTX Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Revolve Group Stock a Buy, Sell or Hold?
Recently, Revolve Group (NYSE:RVLV) management delivered some fairly positive business…
Is Bloom Energy Stock a Buy, Sell or Hold?
While already interesting as the world moves toward greener energy…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
50
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
52
RGC alert for Apr 12
Regencell Bioscience Holdings [RGC] is up 29.14% over the past day.
Buy
52
SLP alert for Apr 12
Simulations Plus [SLP] is up 26.73% over the past day.
Buy
89
GDXU alert for Apr 12
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 15.9% over the past day.
